Researchers conducted the study at a pediatric emergency department in France between January and March 2016. They tested nasopharyngeal aspirates samples from 514 children with flu-like symptoms using a rapid influenza digital immunoassay as well as immunofluorescence and/or molecular routine assays.
The study shows the use of the digital immunoassay at bedside decreased the prescription of:
• Blood puncture by 47.9 percent
• Chest X-rays by 69 percent
• Lumbar puncture by 77.8 percent
• Urine culture by 79.2 percent
Additionally, bedside use of the digital immunoassay reduced antibiotic treatments by 70.1 percent and hospital stays by 25 percent. It also reduced medical costs by an estimated $78,308-plus in a season.
More articles on healthcare quality:
South Carolina patients may need revaccination after hospital error
New Jersey lawmakers look into outbreaks that killed 14 children
U of Wisconsin hospital Legionnaires’ patient dies; 5th case identified
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
